These results indicate that even in breast cancer cells differential levels of MALAT1 could alter alternative splicing of key oncogenic gene mRNAs, preferentially through modulating the activity of SR-splicing factors, such as SRSF1. The gene discussed is SRSF1; the disease is breast carcinoma.